Online Impact
Statistics from Altmetric.com
ARTICLE USAGE
Cited By
Article Information
Volume 7, Issue 8, pp. 1237-1243
PubMed
Published By
Print ISSN
Online ISSN
History
- Received January 3, 2019
- Revision received March 9, 2019
- Accepted June 3, 2019
- Published first June 6, 2019.
Article Versions
- Previous version (June 6, 2019 - 06:46).
- Previous version (June 25, 2019 - 06:46).
- You are viewing the most recent version of this article.
Copyright & Usage
©2019 American Association for Cancer Research.
Author Information
- Shihong Zhang1,
- Karan Kohli1,
- R. Graeme Black1,
- Lu Yao1,
- Sydney M. Spadinger1,
- Qianchuan He2,
- Venu G. Pillarisetty3,
- Lee D. Cranmer1,4,
- Brian A. Van Tine5,
- Cassian Yee6,
- Robert H. Pierce1,
- Stanley R. Riddell1,4,
- Robin L. Jones7, and
- Seth M. Pollack1,4,*
- 1Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, Washington.
- 2Public Health Sciences Division, Fred Hutchinson Cancer Research Center, Seattle, Washington.
- 3Department of Surgery, University of Washington, Seattle, Washington.
- 4Division of Medical Oncology, University of Washington, Seattle, Washington.
- 5Division of Oncology, Washington University in St. Louis, St. Louis, Missouri.
- 6Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
- 7Sarcoma Unit, Royal Marsden Hospital and Institute of Cancer Research, London, UK.
- ↵*Corresponding Author:
Seth M. Pollack, Fred Hutchinson Cancer Research Center, 1100 Fairview Ave N, D3-100, Seattle, WA 98109. Phone: 206-667-6629; E-mail: spollack{at}fredhutch.org
August 2019
Volume 7, Issue 8
Volume 7, Issue 8
Systemic Interferon-γ Increases MHC Class I Expression and T-cell Infiltration in Cold Tumors: Results of a Phase 0 Clinical Trial
Jump to section
Advertisement